“In addition to ESAs, intravenous iron preparations which are commonly used to replenish iron stores in hemodialysis patients can intensify oxidative stress, stimulate monocyte activation and adhesion and promote vascular remodel- ing (17, 18), events that can potentially facilitate target ves- sel re-stenosis following stint placement.”